Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind Study.

CONCLUSION: In patients with breast cancer treated with anthracycline plus cyclophosphamide chemotherapy and receiving the same antiemetic prophylaxis for acute emesis, dexamethasone was not superior to aprepitant but instead had similar efficacy and toxicity in preventing delayed emesis.
PMID: 24323030 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - December 9, 2013 Category: Cancer & Oncology Authors: Roila F, Ruggeri B, Ballatori E, Del Favero A, Tonato M Tags: J Clin Oncol Source Type: research